Predict your next investment

Corporation
HEALTHCARE | Medical Facilities & Services / Specialized Healthcare Services
crosnt.com

See what CB Insights has to offer

Partners & Customers

3

About CROS NT

CROS NT is a global Contract Research Organization (CRO) specialized in clinical data services. With over 800 studies completed in a variety of therapeutic areas and indications, CROS NT has remained focused on biometrics including statistical consultancy, programming and analysis, clinical data management, medical writing, pharmacovigilance and life science technology solutions. It collects, integrates and analyzes data from various sources and uses processes and technology to ensure excellent project governance, reporting, and traceability.On June 8th, 2021, CROS NT was acquired by Alira Health. The terms of the transaction were not disclosed.

CROS NT Headquarter Location

Via Germania 2

Verona, 37136,

Italy

+39 045 820 26 66

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest CROS NT News

PharmiWeb.Jobs Welcomes Cros NT

Oct 22, 2021

PharmiWeb.Jobs Welcomes Cros NT CROS NT in their Own Words We are a global team of passionate specialists delivering innovative, high quality, tailored biometrics solutions. We support you in developing therapeutics for patients in a smarter manner by facilitating digital technologies, data integration, standardisation, visualisation and analytics, and data oversight. As biometrics specialists we have made a difference to over 500 projects, by minimising risk, increasing insight and maximising outcomes for patients. Our core expertise spans clinical data management, biostatistics and statistical programming, with our work on centralised biometrics gaining recognition industry-wide. At CROS NT, our mission is to support our clients in developing therapeutics for patients in a smart, innovative and cost-efficient manner through data-driven expertise, solutions and technology. Editor Details PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings. The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. follow us Version: 2021.8.2.1 You are leaving PharmiWeb.com Disclaimer: You are now leaving PharmiWeb.com website and are going to a website that is not operated by us. We are not responsible for the content or availability of linked sites. ABOUT THIRD PARTY LINKS ON OUR SITE PharmiWeb.com offers links to other third party websites that may be of interest to our website visitors. The links provided in our website are provided solely for your convenience and may assist you in locating other useful information on the Internet. When you click on these links you will leave the PharmiWeb.com website and will be redirected to another site. These sites are not under the control of PharmiWeb.com. PharmiWeb.com is not responsible for the content of linked third party websites. We are not an agent for these third parties nor do we endorse or guarantee their products. We make no representation or warranty regarding the accuracy of the information contained in the linked sites. We suggest that you always verify the information obtained from linked websites before acting upon this information. Also, please be aware that the security and privacy policies on these sites may be different than PharmiWeb.com policies, so please read third party privacy and security policies closely. If you have any questions or concerns about the products and services offered on linked third party websites, please contact the third party directly. Continue

CROS NT Acquisitions

2 Acquisitions

CROS NT acquired 2 companies. Their latest acquisition was PM Clinical - Clinical Division on March 07, 2017.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

3/7/2017

$99M

Acquired Unit

1

9/11/2013

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/7/2017

9/11/2013

Investment Stage

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

Note

Acquired Unit

Subscribe to see more

Sources

1

10

CROS NT Partners & Customers

3 Partners and customers

CROS NT has 3 strategic partners and customers. CROS NT recently partnered with Medidata Solutions on May 5, 2017.

Date

Type

Business Partner

Country

News Snippet

Sources

5/23/2017

Partner

United States

CROS NT Announces Extended Partnership with Medidata – Deploys RaveX.

23 May 2017 -- CROS NT today announced go-live of its RaveX team in an extension of its partnership with Medidata .

2

1/31/2017

Partner

United States

Subscribe to see more

Subscribe to see more

10

8/5/2013

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

5/23/2017

1/31/2017

8/5/2013

Type

Partner

Partner

Partner

Business Partner

Country

United States

United States

United States

News Snippet

CROS NT Announces Extended Partnership with Medidata – Deploys RaveX.

23 May 2017 -- CROS NT today announced go-live of its RaveX team in an extension of its partnership with Medidata .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.